• Tidak ada hasil yang ditemukan

Guideline for the reporting of elevated blood lead levels in the Northern Territory

N/A
N/A
Protected

Academic year: 2024

Membagikan "Guideline for the reporting of elevated blood lead levels in the Northern Territory"

Copied!
5
0
0

Teks penuh

(1)

Guideline for the reporting of elevated blood lead levels in the Northern Territory

June 2017

(2)

2

www.nt.gov.au

Contents

Introduction... 3

Objectives... 3

Case definition ... 3

Obligation to report elevated blood lead levels ... 3

Reporting requirements... 3

Response to a reported elevated blood lead level... 4

Privacy ... 4

Contact details ... 4

Definitions ... 5

(3)

3

www.nt.gov.au

Introduction

This guideline outlines the process for reporting elevated blood lead levels in the Northern Territory (NT).

Under the NT Public and Environmental Health Act (the Act), the Chief Health Officer may make guidelines relating to any matter under this Act except declared activities (Section 101). This guideline is adopted under the Act and sets out the requirements for laboratories and public health agencies in the reporting and managing of information as it relates to a person found to have an elevated blood lead levels.

Objectives

The objective of this guideline is to ensure the systematic reporting of elevated blood lead levels in the NT to the NT Department of Health (NT Health). Accurate and timely surveillance of this public health issue will allow NT Health’s public health agencies, the Centre for Disease Control and

Environmental Health Branch, to support health practitioners, NT Health Services and other relevant authorities to prevent and reduce harmful exposure to lead in the NT.

Case definition

An elevated blood lead level is a blood lead level greater than 5 micrograms per decilitre (mcg/dL) (equivalent to greater than 0.24 micromoles per litre (µmol/L)).

AND

The case has either: not been notified previously; or where a case has been notified previously, the case must have had a blood lead level of 5mcg/dL or less since the date of the last notification.

Obligation to report elevated blood lead levels

If a laboratory receives a result from a pathology investigation that indicates a person has a blood lead level greater than 5 mcg/dL, the person in charge of the laboratory must provide the

information listed in the reporting requirements below to the Centre for Disease Control.

There is no penalty for non-compliance.

Reporting requirements

The person in charge of the laboratory must provide the required information by written correspondence, telephone or facsimile to the Centre for Disease Control.

The following information must be provided regarding the person with elevated blood lead:

- Name

- Address and phone number - Date of birth

- Sex

(4)

4

www.nt.gov.au - Aboriginal status

- Test used to make diagnosis

- Name, address and phone number of the referring practitioner - Whether it was an occupational or non-occupational request - Date the specimen was taken

- Date the result was confirmed - The type of specimen tested

- Name of the laboratory where results were referred for testing

Response to a reported elevated blood lead level

The Centre for Disease Control will record the information provided on the NT Government Notifiable Disease System and coordinate the required public health response.

If a person’s blood lead level was tested as part of occupational screening, NT Worksafe is the agency responsible for follow up.

For non-occupational elevated blood lead levels, the Centre for Disease Control will provide any necessary advice to the attending medical officer with regards to identifying the source of exposure and where relevant, appropriate measures to reduce or prevent further exposures.

The Centre for Disease Control is responsible for maintaining public health and clinical management guidelines for responding to an elevated blood lead level. If an elevated blood lead level is

sufficiently elevated or there are greater public or environmental health concerns, the Centre for Disease Control may disclose to an Environmental Health Officer the details of the person. The Environmental Health Branch may undertake a background audit of lead sources, home risk assessment and/or further environmental sampling as required. Results and remediation

recommendations will be shared with the Centre for Disease Control, the attending medical officer and relevant authorities. The Centre for Disease Control and Environmental Health Branch may involve other relevant authorities to appropriately manage specific lead sources.

Privacy

Information related to persons with elevated blood lead levels falls under the Information Privacy Principles listed in Schedule 2 of the NT Information Act 2015. The management of the information will comply with the Department of Health Privacy Policy.

Contact details

Centre for Disease Control Telephone: 08 8922 8804 Fax: 08 8922 8310

Email: [email protected] NT Worksafe

Telephone: 1800 019 115 Fax: 08 89995141

Email: [email protected]

(5)

5

www.nt.gov.au

Definitions

Centre for Disease Control refers to the NT Department of Health agency charged with the public health management and prevention of notifiable diseases.

Environmental Health Branch refers to the NT Department of Health agency charged with the public health management of physical, chemical, biological and radiological factors in the environment.

Laboratories refer to the accredited pathology organisation that undertakes diagnostic testing of human samples.

Medical Officer means an authorised officer, under the Public and Environmental Health Act, who is a medical practitioner or entitled to be registered as a medical practitioner.

NT Worksafe is the administering body of the NT Work Health and Safety (National Uniform Legislation Act and Regulations.

Referensi

Dokumen terkait

A retrospective study was performed on all blood speci- mens received in Clinical Microbiology Laboratory (CML) of Department of Microbiology, Faculty of Medicine University

An experimental cross-sectional study utilizing 455 blood samples was carried out in a blood donation setting during mobile collection in PDN, Kuala Lumpur, to evaluate

In the use of clozapine, there is a significant increase in the average of random blood glucose between the first month and the second month (p=0.1) with the difference of 6.37

With regard to the high prevalence of opium dependency in Iran and also because of the complicated problems occur as a result of an increase in blood lead level, the present study

Celery seed extract can lead to decreased blood glucose levels and increased serum insulin levels in diabetic rats.20 Celery seeds contain the flavonoids apigenin, luteolin, and

Blood glucose levels and ectoparasite infestation before and after transportation Based on the results of the chi-square test, it was found that there was a relationship between

Lower blood LDL level in the present study compared with a normal level 46.68 – 81.06 ml/dL vs 95 – 125 ml/dL is a result of high MBHI meal level in the diets, so that the diets have

2021 discovered that administration of arabic gum, which has a similar structure and composition to neem gum, orally for 28 days at a dose of 15% resulted in a reduction of blood